Research records indexed for Cortexin
This page carries 12 of the 181 records that the literature query returned for Cortexin, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 169 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Cortexin.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| [Cortexin in the comprehensive therapy of alcoholic encephalopathy] pmid:42360215 | 2026 | English Abstract | other | Not stated | Indexed as english abstract. study model from MeSH "Humans" with no interventional publication type. subject headings: Intercellular Signaling Peptides And Proteins; Neuroprotective Agents; Injections, Intramuscular; Neuropsychological Tests. |
| [Cortexin in the comprehensive treatment of neurological complications of type 2 diabetes mellitus. (Results of the DIACORT multicenter randomized clinical trial)] pmid:42133422 | 2026 | Multicenter Study, Randomized Controlled Trial | human trial | Not stated | Indexed as multicenter study, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Diabetic Neuropathies; Diabetes Mellitus, Type 2; Intercellular Signaling Peptides And Proteins; Peptides; Depression. |
| [Efficacy and safety of Cortexin as additional therapy in patients with depressive disorder] pmid:41782536 | 2026 | English Abstract | other | Not stated | Indexed as english abstract. study model from MeSH "Humans" with no interventional publication type. subject headings: Intercellular Signaling Peptides And Proteins; Peptides; Antidepressive Agents; Drug Therapy, Combination; Depressive Disorder. |
| [Evaluation of the effectiveness of the drug Cortexin in combination with the use of the application Aphasia.No (Afaziyam.Net) in the correction of speech disorders in patients with cerebral infarction] pmid:39690562 | 2024 | English Abstract | other | Not stated | Indexed as english abstract. study model from MeSH "Humans" with no interventional publication type. subject headings: Cerebral Infarction; Speech Disorders; Aphasia; Intercellular Signaling Peptides And Proteins; Aged, 80 And Over. |
| Cortexin® Ameliorates High Glucose-Induced Neuropathy in Cultured Rat Sensory Neurons pmid:37080184 | 2023 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Rats". subject headings: Cells, Cultured; Peripheral Nervous System Diseases; Glucose; Intercellular Signaling Peptides And Proteins; Neuroprotective Agents. |
| [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX] pmid:35175707 | 2022 | Multicenter Study | other | Not stated | Indexed as multicenter study. study model from MeSH "Humans" with no interventional publication type. subject headings: Nervous System Diseases; Syndrome; Intercellular Signaling Peptides And Proteins; Pharmaceutical Preparations; Prevalence. |
| Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats pmid:34260655 | 2021 | research-article | rodent | Not stated | Indexed as research-article. study model from MeSH "Mice". subject headings: Blood-Brain Barrier; Brain; Rats, Wistar; Brain Ischemia; Infarction, Middle Cerebral Artery. |
| [Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency] pmid:34460162 | 2021 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Rats". subject headings: Rats, Wistar; Brain Ischemia; Heme; Intercellular Signaling Peptides And Proteins; Amino Acids. |
| [Cortexin administration due to improvement of cognitive and behavioral disorders in children and teenagers with epilepsy] pmid:33834730 | 2021 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Humans" with no interventional publication type. subject headings: Epilepsy; Intercellular Signaling Peptides And Proteins; Anticonvulsants; Cognition. |
| [Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and morphological changes in the hippocampus of rats with chronic brain ischemia] pmid:32929929 | 2020 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Rats". subject headings: Hippocampus; Rats, Wistar; Brain Ischemia; Heme; Intercellular Signaling Peptides And Proteins. |
| [A multicenter observation study of the efficacy of cortexin and recognan (citicoline) in the treatment of cognitive impairments in chronic cerebrovascular pathology] pmid:30874524 | 2019 | Journal Article | other | Not stated | Indexed as journal article. study model from MeSH "Humans" with no interventional publication type. subject headings: Cytidine Diphosphate Choline; Intercellular Signaling Peptides And Proteins; Peptides; Aged, 80 And Over; Russia. |
| [Evaluation of the efficacy and safety of application of the drug cortexin in the complex rehabilitation of verticalization in patients with ischemic stroke in the acute period] pmid:31626220 | 2019 | Clinical Trial | human trial | Not stated | Indexed as clinical trial. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Brain Ischemia; Intercellular Signaling Peptides And Proteins; Peptides; Stroke. |
Where this page sits
Compound page: Cortexin. Class: Short peptide bioregulators.
Retrieved 2026-10-12.
Sources
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:cortexin
- Identification of cortexin: a novel, neuron-specific, 82-residue membrane protein enriched in rodent cerebral cortex. Journal of neurochemistry (1993). pmid:8336151
- [Cortexin. Molecular mechanisms and targets of neuroprotective activity]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2015). pmid:26356623
- Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats. PloS one (2021). pmid:34260655
- [Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2018). pmid:30335070
- [Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2018). pmid:29652302
- [The efficacy of cortexin and memantinol (memantine) in the treatment of cognitive impairment in patients with chronic cerebral ischemia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2018). pmid:29460902
- [Comparative study of protective effects of Cortexin, Cerebrolysin and Actovegin on memory impairment, cerebral circulation and morphological changes in the hippocampus of rats with chronic brain ischemia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020). pmid:32929929
- [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022). pmid:35175707
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.